KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) EPS (Basic) (2016 - 2026)

Evolent Health has reported EPS (Basic) over the past 12 years, most recently at -$3.84 for Q4 2025.

  • For Q4 2025, EPS (Basic) fell 1322.22% year-over-year to -$3.84; the TTM value through Dec 2025 reached -$5.15, down 528.05%, while the annual FY2025 figure was -$5.07, 525.93% down from the prior year.
  • EPS (Basic) for Q4 2025 was -$3.84 at Evolent Health, down from -$0.24 in the prior quarter.
  • Over five years, EPS (Basic) peaked at $0.03 in Q4 2021 and troughed at -$3.84 in Q4 2025.
  • A 5-year average of -$0.39 and a median of -$0.23 in 2024 define the central range for EPS (Basic).
  • Biggest five-year swings in EPS (Basic): soared 123.08% in 2021 and later plummeted 1600.0% in 2023.
  • Year by year, EPS (Basic) stood at $0.03 in 2021, then tumbled by 466.67% to -$0.11 in 2022, then tumbled by 227.27% to -$0.36 in 2023, then grew by 25.0% to -$0.27 in 2024, then plummeted by 1322.22% to -$3.84 in 2025.
  • Business Quant data shows EPS (Basic) for EVH at -$3.84 in Q4 2025, -$0.24 in Q3 2025, and -$0.44 in Q2 2025.